NASDAQ: SLXN
Silexion Therapeutics Corp Stock Ownership - Who owns Silexion Therapeutics?

Insider buying vs selling

Have Silexion Therapeutics Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mitchell ShirvanCSO and CDO2026-03-2622,818$1.36
$31.03kSell
Ilan LevinDirector2025-09-15450,000$4.00
$1.80MBuy

1 of 1

SLXN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLXN insiders and whales buy or sell their stock.

SLXN Shareholders

What type of owners hold Silexion Therapeutics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ilan Levin100.08%3,333,452$1.91MInsider
Moringa Sponsor LP86.32%2,875,000$1.64MInsider
Ilan Hadar1.97%65,471$37.45kInsider
Hadar Mirit Horenshtein1.51%50,146$28.68kInsider
Mitchell Shirvan0.84%27,889$15.95kInsider
Avner Lushi0.76%25,399$14.53kInsider
Shlomo Noy0.76%25,399$14.53kInsider
Citadel Advisors LLC0.37%12,205$6.98kInstitution
Ruth Alon0.31%10,228$5.85kInsider
Dror Yosef Abramov0.31%10,180$5.82kInsider

1 of 2

SLXN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLXN0.28%99.72%Net BuyingNet Selling
PBM2.12%97.88%
ARTL10.57%89.43%
PPCB0.81%0.00%
ADIL52.61%47.39%

Silexion Therapeutics Stock Ownership FAQ

Who owns Silexion Therapeutics?

Silexion Therapeutics (NASDAQ: SLXN) is owned by 0.55% institutional shareholders, 193.09% Silexion Therapeutics insiders, and 0.00% retail investors. Ilan Levin is the largest individual Silexion Therapeutics shareholder, owning 3.33M shares representing 100.08% of the company. Ilan Levin's Silexion Therapeutics shares are currently valued at $1.73M.

If you're new to stock investing, here's how to buy Silexion Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.